INT'L GROUP(000411)2022-12-06 05:10Group 1: Company Overview - The company aims to become "China's best pharmaceutical health service provider" with a focus on "internal growth, external expansion, integrated development, and innovative enhancement" [3] - The core business is pharmaceutical distribution, with strategic focuses on traditional Chinese medicine, health products, biological products, and medical devices [4] Group 2: Mergers and Acquisitions - The company has been actively pursuing mergers and acquisitions, completing partnerships with 11 regional subsidiaries from 2009 to 2011 [3] - In 2016, the company successfully completed equity cooperation with Zhoushan Yinte Weisheng and Taizhou Yinte Pharmaceutical, enhancing its provincial layout [4] Group 3: Quality Management - The company adheres to a quality policy of "quality first, integrity-based," optimizing quality management processes and strengthening risk control [4] Group 4: E-commerce and Information Technology - The company is developing e-commerce, with its subsidiary Yinte Yinian Pharmacy operating on platforms like Tmall and Weidian, targeting individual consumers [4] - The company has established an e-commerce division and aims to integrate distribution, logistics, and e-commerce into a unified information technology strategy [5] Group 5: Market Coverage - The company is a leading pharmaceutical distribution enterprise in Zhejiang Province, achieving full coverage of medical institutions at the county level and above [5] - The actual coverage rate for basic drug distribution exceeds 86.7%, with over 70 counties/cities/districts included in the bidding area [5]